Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 458

Results For "NAL"

6624 News Found

UK Parliament honours All India Institute of Ayurveda’s Director Dr Tanuja Nesari with Ayurveda Ratna Award
News | July 02, 2022

UK Parliament honours All India Institute of Ayurveda’s Director Dr Tanuja Nesari with Ayurveda Ratna Award

The award was presented to her during a virtual ceremony on the occasion of 8th International Day of Yoga on 21st June 2022.


Maria Soler Nunez appointed Head, Group Operations of Lonza
People | July 02, 2022

Maria Soler Nunez appointed Head, Group Operations of Lonza

Prior to this, Maria held multiple roles at Novartis including Head of Global Manufacturing Functions, and Global Head of Manufacturing, Science & Technology


Lonza to invest 500 mn in commercial drug product fill & finish facility
News | July 02, 2022

Lonza to invest 500 mn in commercial drug product fill & finish facility

The investment will enable the company to provide customers with a complete and integrated end-to-end solution


Ardelyx gets into $20 million financing agreement with HealthCare Royalty Partners
News | July 02, 2022

Ardelyx gets into $20 million financing agreement with HealthCare Royalty Partners

HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States


NITI Aayog releases a compendium of Ayush-based practices
News | July 02, 2022

NITI Aayog releases a compendium of Ayush-based practices

The compendium was released by Suman Bery, Vice-Chairman, NITI Aayog and Dr. Munjpara Mahendrabhai Kalubhai, Minister of State for Ayush and WCD.


Akebia Therapeutics regaining rights to Vadadustat in the US, Europe and China
News | July 01, 2022

Akebia Therapeutics regaining rights to Vadadustat in the US, Europe and China

Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia


Jubilant HollisterStier announces CAD 100 mn for Montreal facility
News | July 01, 2022

Jubilant HollisterStier announces CAD 100 mn for Montreal facility

The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million


Lupin receives approval from USFDA for Paliperidone extended-release tablets
Drug Approval | July 01, 2022

Lupin receives approval from USFDA for Paliperidone extended-release tablets

Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S


JB Pharma acquires 4 paediatric brands from Dr Reddy’s Laboratories
News | July 01, 2022

JB Pharma acquires 4 paediatric brands from Dr Reddy’s Laboratories

The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores


MTPA announces long-term findings from post-marketing safety study of Radicava
News | June 30, 2022

MTPA announces long-term findings from post-marketing safety study of Radicava

Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone